CLASS II Drug recall · Reported 17 Jun 2015 · FDA Enforcement Report

MD-Gastroview (Diatrizoate Meglumine recalled by Mallinckrodt

Mallinckrodt is recalling MD-Gastroview (Diatrizoate Meglumine and Diatrizoate Sodium Solution USP). The recall was initiated on 15 May 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: B201B, Exp April 2015; B346D, Exp August 2015.
NDC0019-4816
UPC0300194816044
Quantity recalled6600 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1132-2015
FDA event ID
71220
Recalling firm
Mallinckrodt, Hazelwood, MO
Manufacturer
Liebel-Flarsheim Company LLC
Classification
Class II
Status
Terminated
Recall initiated
15 May 2015
FDA classified
10 Jun 2015
Reported
17 Jun 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

15 May 2015Recall initiated by company
10 Jun 2015Classified by FDA+26 days
17 Jun 2015Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: incorrect or missing lot number and/or expiration date

Product as listed by the FDA

MD-Gastroview (Diatrizoate Meglumine and Diatrizoate Sodium Solution USP); 37% Organically Bound Iodine For Gastrointestinal Radiography; Oral or rectal use only; Rx only; 30 mL; Single-Unit Container; ; Mallinckrodt Inc., St. Louis, MO 63042. NDC 0019-4816-04

Where it was distributed

Costa Rica

Questions about this recall

Why was it recalled?

Labeling: incorrect or missing lot number and/or expiration date

Which lots are affected?

Lot #: B201B, Exp April 2015; B346D, Exp August 2015.

Where was it sold?

Costa Rica

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Mallinckrodt

All 6

Other Diatrizoate Meglumine recalls

All 3